G. Wágner

发表

4-Aryl-3-arylsulfonyl-quinolines as negative allosteric modulators of metabotropic GluR5 receptors: From HTS hit to development candidate.

J. Galambos, G. Keserű, Z. Szakács, 2016, Bioorganic & medicinal chemistry letters.

Carbamoyloximes as novel non-competitive mGlu5 receptor antagonists.

J. Galambos, B. Kiss, L. Molnár, 2010, Bioorganic & medicinal chemistry letters.

Hit-to-lead optimization of disubstituted oxadiazoles and tetrazoles as mGluR5 NAMs.

B. Kiss, L. Molnár, G. Keserű, 2010, Bioorganic & medicinal chemistry letters.

SAR exploration of the non‐imidazole histamine H3 receptor ligand ZEL‐H16 reveals potent inverse agonism

I. D. de Esch, R. Leurs, C. de Graaf, 2022, Archiv der Pharmazie.

Covalent Inhibition of the Histamine H3 Receptor

I. D. de Esch, R. Leurs, G. Keserű, 2019, Molecules.

4-(3-Aminoazetidin-1-yl)pyrimidin-2-amines as High-Affinity Non-imidazole Histamine H3 Receptor Agonists with in Vivo Central Nervous System Activity

I. D. de Esch, R. Leurs, K. Kieć‐Kononowicz, 2019, Journal of medicinal chemistry.

Discovery and Preclinical Characterization of 3-((4-(4-Chlorophenyl)-7-fluoroquinoline-3-yl)sulfonyl)benzonitrile, a Novel Non-acetylenic Metabotropic Glutamate Receptor 5 (mGluR5) Negative Allosteric Modulator for Psychiatric Indications.

J. Galambos, G. Balogh, G. Keserű, 2017, Journal of medicinal chemistry.

Charting the chemical space around the (iso)indoline scaffold, a comprehensive approach towards multitarget directed ligands.

Z. Kovács, Ákos Tarcsay, Z. Némethy, 2016, Bioorganic & medicinal chemistry letters.

Discovery of 4-amino-3-arylsulfoquinolines, a novel non-acetylenic chemotype of metabotropic glutamate 5 (mGlu5) receptor negative allosteric modulators.

J. Galambos, B. Kiss, G. Keserű, 2017, European journal of medicinal chemistry.